IDEXX Laboratories, Inc. (IDXX)
After hours:
| Previous close | 495.95 |
| Open | 494.84 |
| Bid | 489.61 x 100 |
| Ask | 490.89 x 200 |
| Day's range | 475.62 - 494.84 |
| 52-week range | 372.50 - 583.39 |
| Volume | |
| Avg. volume | 512,993 |
| Market cap | 40.351B |
| Beta (5Y monthly) | 1.33 |
| PE ratio (TTM) | 48.69 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
IDEXX Laboratories to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
WESTBROOK, Maine, August 21, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the Morgan Stanley 22nd Annual Global Healthcare Conference on Wednesday, September 4, 2024 from 11:30 am – 12:05 pm (EDT).
- Business Wire
IDEXX Laboratories Announces Second Quarter Results
WESTBROOK, Maine, August 06, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results.
- Business Wire
IDEXX Laboratories Announces Time Change for 2024 Second Quarter Financial Results Conference Call
WESTBROOK, Maine, July 30, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will now host its 2024 second quarter conference call and webcast at 9:00 am ET on Tuesday, August 6, 2024, to minimize conflicts with other industry earnings announcements.
